OTLK logo
OTLK

Outlook Therapeutics Inc

Biotechnology

Outlook Therapeutics Inc (OTLK) Insider Trading

7 transactions reported on SEC Form 4 — executive and director buys and sells.

🔥
Cluster Buy Signal
3+ insiders bought OTLK in the last 30 days — often a sign of internal confidence.
Buys
4
Sells
0
Net value
$2.5M
InsiderTitleTypeSharesValueDate
KENYON LAWRENCE AChief Financial OfficerBuy101,0103d ago
Sukhtian Ghiath M.Buy2,525,252$2.5M5d ago
Jahr Robert CharlesChief Executive OfficerBuy151,5153d ago
Jahr Robert CharlesChief Executive OfficerGrant100,00027d ago
KENYON LAWRENCE AChief Financial OfficerGrant210,07827d ago
Sukhtian Ghiath M.Buy8,539,709$0May 28, 2026
Sukhtian Ghiath M.H3,458,571May 28, 2026